FV Hospital, a Vietnam-headquartered tertiary care provider, is reviewing a plethora of strategic options to provide an exit route to its existing investor Quadria Capital, its CEO Jean-Marcel Guillon told DealStreetAsia.
While the company is open to a strategic sale, it is also weighing options for a proposed IPO in the domestic market. Talks are at a preliminary stage and “no external advisor has been appointed so far,” said Guillon. A decision is likely to be taken by the end of the year even as the company did not give any timeframe when Quadria could exit.
Quadria invested in FV Hospital in July 2017 through Quadria Capital Fund L.P, with participation from Neuberger Berman Private Equity and German Investment & Development Corporation (DEG), a subsidiary of KfW.
Even as the deal size could not be ascertained, it is understood that the PE firm that specializes in healthcare investments across Asia holds a significant stake in the hospital.
The acquisition of FV Hospital marked the seventh investment of Quadria Capital since 2015.
FV Hospital was founded in 2003 by Guillon along with a group of French physicians. Located in District 7 of Ho Chi Minh City, FV Hospital has over 220 beds and provides over 30 medical specialties. Besides the hospital, the company also operates an outpatient clinic at District 1, Ho Chi Minh City. FV Hospital has more than 950 service staff.
Quadria recently made headlines when it received a $150-million commitment from Overseas Private Investment Corporation (OPIC), the development finance arm of the US government, for its latest fund that is targeting a corpus of around $700 million.
It is looking to exit a slew of portfolio companies such as Indonesian pharmaceutical firm Soho Global Health and India’s Medica Synergie as reported by DealStreetAsia.
Soho has reportedly appointed Citigroup, Mandiri Sekuritas and CLSA for a proposed IPO, while Advay Capital is facilitating the transaction for Medica Synergie.